Seneca Biopharma, Inc.
(NASDAQ : CUR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.00%572.402.7%$664.87m
AMGNAmgen, Inc. -0.76%227.221.3%$582.69m
ILMNIllumina, Inc. 2.00%324.193.5%$566.54m
GILDGilead Sciences, Inc. -0.02%60.201.0%$501.27m
MRNAModerna, Inc. 3.63%70.850.0%$488.84m
VRTXVertex Pharmaceuticals, Inc. -0.30%210.741.9%$486.87m
ARRYArray BioPharma Inc. 0.92%39.7014.2%$482.74m
IMMUImmunomedics, Inc. 0.05%87.8611.0%$373.44m
NVAXNovavax, Inc. 2.25%93.2196.5%$309.60m
ALXNAlexion Pharmaceuticals, Inc. 1.77%120.282.0%$285.37m
BIIBBiogen, Inc. -1.80%264.061.6%$259.83m
EXASEXACT Sciences Corp. 7.36%106.9420.7%$235.70m
BNTXBioNTech SE -1.81%86.130.0%$210.78m
SRNESorrento Therapeutics, Inc. 4.97%8.241.4%$190.34m
SGENSeagen Inc. 1.65%200.976.0%$165.04m

Company Profile

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.